Icon

Isentress - (400 mg; Tablet)

Raltegravir Potassium Merck
400 mg; Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
Less Than 5
None None
ISENTRESS™ is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: In combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
Yes
***** ** *** *** *** ********* *** *** ******* ** *** ******* **** *******. ** *** ****, ***** **** ****** **** ************ ** ****** '***. ********* ** *****'* *** ******, ***** ****** *** ********* ******* ** **** ** *** **.
Isentress Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6
****** *** ********* *** ********* *** ********* ******* ***** ******** ************ *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ********* -**- ******* ********* ******** ******* *** **** *** **** ****
  1. *** **, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** *, **** : ****** ******** ***** ** ***** **** ** ******.
  3. *** **, **** : ****** ******** ********* ******** **** *** *** *** *** *********
  4. *** **, **** : ***** **** ****** **** ************ ** ****** '***.
  5. *** **, **** : ***** *** ****** **** ******* ********** **** ******* *****. ****** ****** ********** ****** **. '***.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.